News, Analysis & Insights on Nutrition, Supplements, and Health
The seventh Vitafoods tradeshow upheld its reputation as Europe's major trading arena in health ingredients but also brought into focus the future impact of a wave of European regulation on the functional foods and supplements industries.
The French food authority AFSSA has approved a health claim for cranberry juice and powder and its effect on urinary tract health, in the world's first health claim for the fruit, writes Philippa Nuttall.
Antioxidants found in oats can significantly reduce blood cholesterol levels by suppressing the adhesive molecules which make blood cells stick to artery walls, report scientists from the US this week - evidence of the cholesterol-busting properties...
The UK's number one supermarket is introducing new food labels that rank a product according to its position on the glycemic index, a system that measures the effects of food on blood sugar levels.
San Diego-based Alpha Nutraceuticals has bought the business and assets of Californian supplement maker Avidia Nutritional Group, boosting its manufacturing capacity to allow for expansion.
Dr Pepper/Seven Up (DPSU), the Texas-based drinks division of Cadbury Schweppes, today announced plans to introduce 7 Up Plus, said to be the first carbonated beverage to be fortified with calcium, vitamin C and fruit juice.
An upcoming conference on the enzyme superoxide dismutase looks set to provoke a face-off between leading researchers on the role of antioxidants in disease.
A Tufts University team has discovered that compounds in oats hinder the ability of cholesterol to stick to artery walls, thereby preventing the build-up of plaques that block arteries and endanger heart health.
Scientists have discovered a protein that controls the amount of fat stored in the body, offering potential new clues for obesity treatments - welcome news as the world's health leaders agree to do more to tackle the growing problem.
Japanese supplement business Shaklee has been bought by two private equity firms for approximately $310 million from Yamanouchi Pharmaceutical.